Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide in head and neck cancer: the CONFRONT phase I-II trial

Authors: Merlano, M.C. ^{1, †}, Denaro, N. ^{2, †}, Paccagnella, M. ^{3, 4, ∗}, Abbona, A. ^{3, 4}, Galizia, D. ⁵, Alfieri, S. ⁶, Bergamini, C. ⁶, Orlandi, E. ⁶, Merlotti, A.M. ⁷, Bondi, S. ¹, Licitra, L. ^{6, 8, ‡}, Garrone, O. ^{2, ‡}

Source: In ESMO Open April 2025 10(4)

Sinonasal malignancy: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

Authors: Resteghini, C. ^{1, 2}, Baujat, B. ³, Bossi, P. ^{2, 4}, Franchi, A. ⁵, de Gabory, L. ⁶, Halamkova, J. ^{7, 8}, Haubner, F. ⁹, Hardillo, J.A.U. ¹⁰, Hermsen, M.A. ¹¹, Iacovelli, N.A. ¹², Maroldi, R. ¹³, Mattheis, S. ¹⁴, Moya-Plana, A. ¹⁵, Nicolai, P. ¹⁶, Orlandi, E. ^{17, 18}, Thariat, J. ^{19, 20}, Trama, A. ²¹, van den Brekel, M.W.M. ^{22, 23, 24}, van Herpen, C.M.L. ²⁵, Verillaud, B. ²⁶, Kinloch, E. ²⁷, Licitra, L. ^{1, 28, †}, Even, C. ^{29, †}

Source: In ESMO Open February 2025 10(2)

Systemic treatments in recurrent or metastatic salivary gland cancer: a systematic review

Authors: Prost, D., Iseas, S., Gatineau, M., Adam, J., Cavalieri, S., Bergamini, C., Licitra, L., Raymond, É.

Source: In ESMO Open October 2024 9(10)

Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors

Authors: Lewis, K.D., Peris, K., Sekulic, A., Stratigos, A.J., Dunn, L., Eroglu, Z., Chang, A.L.S., Migden, M.R., Yoo, S.-Y., Mohan, K., Coates, E., Okoye, E., Bowler, T., Baurain, J.-F., Bechter, O., Hauschild, A., Butler, M.O., Hernandez-Aya, L., Licitra, L., Neves, R.I., Ruiz, E.S., Seebach, F., Lowy, I., Goncalves, P., Fury, M.G.

Source: In Annals of Oncology February 2024 35(2):221-228

Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence

Authors: Harrington, K.J., Cohen, E.E.W., Soulières, D., Dinis, J., Licitra, L., Ahn, M.-J., Soria, A., Machiels, J.-P., Mach, N., Mehra, R., Burtness, B., Swaby, R.F., Lin, J., Ge, J., Lerman, N., Tourneau, C. Le

Source: In Oral Oncology December 2023 147

Pan-Asian adaptation of the EHNS–ESMO–ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck

Authors: Keam, B., Machiels, J.-P., Kim, H.R., Licitra, L., Golusinski, W., Gregoire, V., Lee, Y.G., Belka, C., Guo, Y., Rajappa, S.J., Tahara, M., Azrif, M., Ang, M.K., Yang, M.-H., Wang, C.-H., Ng, Q.S., Wan Zamaniah, W.I., Kiyota, N., Babu, S., Yang, K., Curigliano, G., Peters, S., Kim, T.W., Yoshino, T., Pentheroudakis, G.

Source: In ESMO Open December 2021 6(6)

Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis

Authors: Adelstein, D.J., Agarwal, J., Alfonsi, M., Argiris, A., Aupérin, A., Bacigalupo, A., Bar-Ad, V., Bartelink, H., Beadle, B., Belkacemi, Y., Bensadoun, R.J., Bernier, J., Blanchard, P., Bourhis, J., Bratland, Å., Brizel, D., Budach, V., Budach, W., Burtness, B., Calais, G., Campbell, B., Caudell, J., Chabaud, S., Chamorey, E., Chaukar, D., Cheugoua-Zanetsie, M., Cho, K.H., Choussy, O., Cruz Hernandez, J.J., Denham, J.W., Dobrowsky, W., Dominello, M.M, Driessen, C.M.L., Fallai, C., Forastiere, A.A., Fortpied, C., Fountzilas, G., Garaud, P., Garden, A.S., Gery, B., Ghadjar, P., Ghi, M.G., Ghosh Laskar, S., Graff-Cailleaud, P., Grau, C., Gregoire, V., Hackshaw, A., Haddad, E, Haffty, B.G., Hansen, A., Hay, J.H., Hayoz, S., Horiot, J.C., Hitt, R., Jeremic, B., Johansen, J., Jones, C., Julieron, M., Kristensen, C.A., Kumar, S., Lacas, B., Langendijk, J.A., Lapeyre, M., Lartigau, E., Licitra, L., Le, Q.T., Lee, J.W., Lee, P., Lewin, F., Li, Y., Lopes, A., Lotayef, M., Maciejewski, B., Mazeron, J.J., Mehta, S., Michalski, W., Moon, J., Moon, S.H., Moyal, E., Nankivell, M., Nilsson, P., Olmi, P., Orecchia, R., O'Sullivan, B., Overgaard, J., Parmar, M.K.B., Petit, C., Pignon, J.P., Pointreau, Y., Posner, M.R., Poulsen, M.G., Quon, H., Racadot, S., Rosenthal, D.I., Rovea, P., Ruo Redda, M.G., Sanguineti, G., Shenouda, G., Simes, J., Sharma, A., Simon, C., Sire, C., Skladowski, K., Spencer, S., Staar, S., Strojan, P., Stromberger, C., Suwinski, R., Szutkowski, Z., Takácsi-Nagy, Z., Tao, Y.G., Temam, S., Thomson, D., Tobias, J.S., Torres-Saavedra, P., Torri, V., Tripcony, L., Trotti, A., Tseroni, V., van Herpen, C., van Tinteren, H., Vermorken, J., Viegas, C.M.P., Vokes, E.E., Waldron, J., Wernecke, K.D, Widder, J., Wolf, G.T., Wong, S.J., Wu, J.S., Yamazaki, H., Zaktonik, B., Zackrisson, B., Zhong, L.P., Petit, Claire, Lacas, Benjamin, Pignon, Jean-Pierre, Le, Quynh Thu, Grégoire, Vincent, Grau, Cai, Hackshaw, Allan, Zackrisson, Björn, Parmar, Mahesh K B, Lee, Ju-Whei, Ghi, Maria Grazia, Sanguineti, Giuseppe, Temam, Stéphane, Cheugoua-Zanetsie, Maurice, O'Sullivan, Brian, Posner, Marshall R, Vokes, Everett E, Cruz Hernandez, Juan J, Szutkowski, Zbigniew, Lartigau, Eric, Budach, Volker, Suwiński, Rafal, Poulsen, Michael, Kumar, Shaleen, Ghosh Laskar, Sarbani, Mazeron, Jean-Jacques, Jeremic, Branislav, Simes, John, Zhong, Lai-Ping, Overgaard, Jens, Fortpied, Catherine, Torres-Saavedra, Pedro, Bourhis, Jean, Aupérin, Anne, Blanchard, Pierre ^*

Source: In The Lancet Oncology May 2021 22(5):727-736

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

Authors: Bossi, P., Chan, A.T., Licitra, L., Trama, A., Orlandi, E., Hui, E.P., Halámková, J., Mattheis, S., Baujat, B., Hardillo, J., Smeele, L., van Herpen, C., Castro, A., Machiels, J.-P.

Source: In Annals of Oncology April 2021 32(4):452-465

Reprint of “Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up”

Authors: Machiels, J.-P., René Leemans, C., Golusinski, W., Grau, C., Licitra, L., Gregoire, V.

Source: In Oral Oncology February 2021 113

Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Authors: Machiels, J.-P., René Leemans, C., Golusinski, W., Grau, C., Licitra, L., Gregoire, V.

Source: In Annals of Oncology November 2020 31(11):1462-1475

Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

Authors: Ferris, R.L., Haddad, R., Even, C., Tahara, M., Dvorkin, M., Ciuleanu, T.E., Clement, P.M., Mesia, R., Kutukova, S., Zholudeva, L., Daste, A., Caballero-Daroqui, J., Keam, B., Vynnychenko, I., Lafond, C., Shetty, J., Mann, H., Fan, J., Wildsmith, S., Morsli, N., Fayette, J., Licitra, L.

Source: In Annals of Oncology July 2020 31(7):942-950

Forecasting the performance status of head and neck cancer patient treatment by an interval arithmetic pruned perceptron

Authors: Drago, G.P., Setti, E., Licitra, L., Liberati, D.

Source: IEEE Transactions on Biomedical Engineering IEEE Trans. Biomed. Eng. Biomedical Engineering, IEEE Transactions on. 49(8):782-787 Aug, 2002

Difficulties in conducting pure academic research, obstacles in data collection and quality of informations: The example of the INTERCEPTOR study

Authors: Merlano, M., Denaro, N., Benasso, M., Licitra, L., Bossi, P., Locati, L., Vecchio, S., Bruzzi, P.

Source: In Oral Oncology October 2019 97:99-104

A-626 - Italian interim analysis of the multinational, post-authorisation safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma: focus on time to onset of adverse events

Authors: Scarpato, L. ¹, Ascierto, P.A. ¹, Scalvenzi, M. ², Villani, A. ², Bossi, P. ³, Alberti, A. ⁴, Giorgi, V. De ⁵, Licitra, L. ⁶, Fargnoli, M.C. ⁷, Savoia, P. ⁸, Guida, M. ⁹, Spagnolo, F. ¹⁰, Galitiis, F. De ¹¹, Stanganelli, I. ¹², Peris, K. ¹³

Source: In EJC Skin Cancer 2025 3 Supplement 1

Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma

Authors: van Boxtel, W., Locati, L.D., van Engen-van Grunsven, A.C.H., Bergamini, C., Jonker, M.A., Fiets, E., Cavalieri, S., Tooten, S., Bos, E., Quattrone, P., Verhaegh, G.W., Schalken, J.A., Licitra, L., van Herpen, C.M.L.

Source: In European Journal of Cancer March 2019 110:62-70

Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach

Authors: Galot, R., Le Tourneau, C., Guigay, J., Licitra, L., Tinhofer, I., Kong, A., Caballero, C., Fortpied, C., Bogaerts, J., Govaerts, A.-S., Staelens, D., Raveloarivahy, T., Rodegher, L., Laes, J.-F., Saada-Bouzid, E., Machiels, J.-P. ^*

Source: In Annals of Oncology December 2018 29(12):2313-2327

Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer

Authors: Cavalieri, S., Perrone, F., Miceli, R., Ascierto, P.A., Locati, L.D., Bergamini, C., Granata, R., Alfieri, S., Resteghini, C., Galbiati, D., Busico, A., Paielli, N., Patuzzo, R., Maurichi, A., Gallino, G., Ruggeri, R., Mariani, L., Palla, M., Licitra, L., Bossi, P.

Source: In European Journal of Cancer July 2018 97:7-15

Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial

Authors: Basset-Séguin, N., Hauschild, A., Kunstfeld, R., Grob, J., Dréno, B., Mortier, L., Ascierto, P.A., Licitra, L., Dutriaux, C., Thomas, L., Meyer, N., Guillot, B., Dummer, R., Arenberger, P., Fife, K., Raimundo, A., Dika, E., Dimier, N., Fittipaldo, A., Xynos, I., Hansson, J.

Source: In European Journal of Cancer November 2017 86:334-348

Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma

Authors: Schlumberger, M. ^*, Elisei, R., Müller, S., Schöffski, P., Brose, M., Shah, M., Licitra, L., Krajewska, J., Kreissl, M.C., Niederle, B., Cohen, E.E.W., Wirth, L., Ali, H., Clary, D.O., Yaron, Y., Mangeshkar, M., Ball, D., Nelkin, B., Sherman, S.

Source: In Annals of Oncology November 2017 28(11):2813-2819

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Authors: Bossi, P., Miceli, R., Locati, L.D., Ferrari, D., Vecchio, S., Moretti, G., Denaro, N., Caponigro, F., Airoldi, M., Moro, C., Vaccher, E., Sponghini, A., Caldara, A., Rinaldi, G., Ferrau, F., Nolè, F., Lo Vullo, S., Tettamanzi, F., Hollander, L., Licitra, L. ^*

Source: In Annals of Oncology November 2017 28(11):2820-2826